Harcharan Gill

Publications

• Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC). Harshman LC, Yu RJ, Allen GI, Srinivas S, Gill HS, Chung BI. Urol Oncol. 2013; 31 (3): 379-85
• MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia. Ghanouni P, Gill H, Kaye E, Pauly KB, Daniel B. J Vasc Interv Radiol. 2011; 22 (10): 1427-30
• Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Woo HH, Chin PT, McNicholas TA, Gill HS, Plante MK, Bruskewitz RC, Roehrborn CG. BJU Int. 2011; 108 (1): 82-8
• Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL. Proc Natl Acad Sci U S A. 2009; 106 (33): 14016-21
• Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases. Bosev D, Nicoll LM, Bhagan L, Lemyre M, Payne CK, Gill H, Nezhat C. J Urol. 2009; 182 (6): 2748-52
• MR imaging-guided percutaneous cryoablation of the prostate in an animal model: in vivo imaging of cryoablation-induced tissue necrosis with immediate histopathologic correlation. van den Bosch MA, Josan S, Bouley DM, Chen J, Gill H, Rieke V, Butts-Pauly K, Daniel BL. J Vasc Interv Radiol. 2009; 20 (2): 252-8
• Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC. Int J Radiat Oncol Biol Phys. 2009; 73 (4): 1043-8
• Gross hematuria from an ileal conduit as a first presentation of portal hypertension. Tu WH, Chao D, Gill H. Nat Clin Pract Urol. 2008; 5 (10): 569-73
• Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy. King CR, Presti JC, Brooks JD, Gill H, Spiotto MT. Int J Radiat Oncol Biol Phys. 2008; 70 (5): 1472-7
• Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade. King CR, McNeal JE, Gill H, Brooks JD, Srinivas S, Presti JC. Urology. 2006; 67 (6): 1229-34
• Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Zhou JS, Pillidge CJ, Gopal PK, Gill HS. Int J Food Microbiol. 2005; 98 (2): 211-7
• Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy. Patel DA, Presti JC, McNeal JE, Gill H, Brooks JD, King CR. J Clin Oncol. 2005; 23 (25): 6157-62
• Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients. King CR, McNeal JE, Gill H, Presti JC. Int J Radiat Oncol Biol Phys. 2004; 59 (2): 386-91
• Gender differences in radical cystectomy: complications and blood loss. Lee KL, Freiha F, Presti JC, Gill HS. Urology. 2004; 63 (6): 1095-9
• Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes? King CR, Presti JC, Gill H, Brooks J, Hancock SL. Int J Radiat Oncol Biol Phys. 2004; 59 (2): 341-7
• Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ, Fero M, Pollack JR, van de Rijn M, Brooks JD. Am J Pathol. 2003; 162 (3): 925-32
• Partial nephrectomy and caval thrombectomy for renal cell carcinoma in a solitary kidney with an accessory renal vein. Pruthi RS, Angell SK, Brooks JD, Gill H. BJU Int. 1999; 83 (1): 142-3
• Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sözen S, Gill H. J Urol. 1998; 160 (6 Pt 2): 2412-7
• Pelvi-ureteric junction obstruction treated with Acucise retrograde endopyelotomy. Gill HS, Liao JC. Br J Urol. 1998; 82 (1): 8-11
• Testicular teratoma with a unique mode of spread and spontaneous maturation. Angell SK, Pruthi R, Gill H. Urol Int. 1998; 61 (2): 119-20
• Prospective multicenter ProLase II clinical trial of neodymium:yttrium-aluminum-garnet laser prostatectomy. Kabalin JN, Gill HS, Leach GE, Bowers GW, Nill T, Konowalchuk TW. Urology. 1997; 50 (1): 63-5
• Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. Kabalin JN, Gill HS, Bite G, Wolfe V. J Urol. 1995; 153 (1): 94-7; discussion 97-8
• Laser prostatectomy performed with a right-angle firing neodymium:YAG laser fiber at 60 watts power setting. Kabalin JN, Gill HS, Bite G. J Urol. 1995; 153 (5): 1502-5
• Characterization of tissue effects produced by the Prolase II lateral-firing neodymium:YAG laser fiber in the canine prostate. Gill HS, Kabalin JN, Mikus PW. Lasers Surg Med. 1994; 15 (2): 185-90
• Dosimetry studies utilizing the Urolase right angle firing neodymium:YAG laser fiber. Kabalin JN, Gill HS. Lasers Surg Med. 1994; 14 (2): 145-54
• Functional and urodynamic characteristics of an ileal neobladder. Iwakiri J, Gill H, Anderson R, Freiha F. J Urol. 1993; 149 (5): 1072-6
• Incidence and management of autonomic dysreflexia and other intraoperative problems encountered in spinal cord injury patients undergoing extracorporeal shock wave lithotripsy without anesthesia on a second generation lithotriptor. Kabalin JN, Lennon S, Gill HS, Wolfe V, Perkash I. J Urol. 1993; 149 (5): 1064-7
• Urolase laser prostatectomy in patients on warfarin anticoagulation: a safe treatment alternative for bladder outlet obstruction. Kabalin JN, Gill HS. Urology. 1993; 42 (6): 738-40
• Adenocarcinoma of the urinary bladder. Gill HS, Dhillon HK, Woodhouse CR. Br J Urol. 1989; 64 (2): 138-42
• Functional and biochemical alterations in the rabbit urinary bladder following ileocystoplasty. Gill HS, Wein AJ, Ruggieri MR, Whitmore KE, Levin RM. J Urol. 1989; 142 (3): 860-4
• Pharmacological comparison of the isolated whole urethra model to urethral strip methodology. Chun AL, Gill HS, Wein AJ, Levin RM. Pharmacology. 1989; 39 (3): 192-9
• Comparative study of two computerized semen motility analyzers. Gill HS, Van Arsdalen K, Hypolite J, Levin RM, Ruzich JV. Andrologia. 1988 Sep-Oct; 20 (5): 433-40
• Defective antiadherence activity of bladder extracts from patients with recurrent urinary tract infection. Ruggieri MR, Levin RM, Hanno PM, Witkowski BA, Gill HS, Steinhardt GF. J Urol. 1988; 140 (1): 157-9
• Effect of bethanechol on glycolysis and high energy phosphate metabolism of the rabbit urinary bladder. Levin RM, Ruggieri MR, Gill HS, Haugaard N, Wein AJ. J Urol. 1988; 139 (3): 646-9
• The effects of short-term in-vivo ischemia on the contractile function of the rabbit urinary bladder. Gill HS, Monson FC, Wein AJ, Ruggieri MR, Levin RM. J Urol. 1988; 139 (6): 1350-4
• Mild metabolic hyperoxaluria and its response to pyridoxine. Gill HS, Rose GA. Urol Int. 1986; 41 (5): 393-6
• Idiopathic hypercalciuria. Urate and other ions in urine before and on various long term treatments. Gill HS, Rose GA. Urol Res. 1985; 13 (6): 271-5
• Occurrence of Toxoplasma gondii antibodies in Tanzanian blood donors. Gill HS, East Afr Med J. 1985; 62 (8): 585-8
• Chloroquine-resistant falciparum malaria in semi-immune African Tanzaniana. Kihamia CM, Gill HS. Lancet. 1982; 2 (8288): 43
• Prevalence of Toxoplasma antibodies in pregnant African women in Tanzania. Gill HS, Mtimavalye LA. Afr J Med Med Sci. 1982; 11 (4): 167-70